Source: International Congress 2018 – Biomarkers in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Bryant (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), A. Yousuf (Leicester, United Kingdom), R. Cordell (Leicester, United Kingdom), M. Wilde (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), P. Monks (Leicester, United Kingdom). Investigating the reproducibility of real time breath measurements using proton transfer reaction - time of flight - mass spectrometry for breath of volatile organic compounds in COPD Patients.. 3581

Member's Comments

No comment yet.

Related content which might interest you: How to measure exhaled breath MDA in normal subjects: assessment of two ionisation modes used by LC-MS/MS. Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008 Comparison of indirect measurements of multiple breath nitrogen washout with mass spectrometry. Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions Year: 2019 Real time mass spectrometric analysis of biomarkers in exhaled breath after exposure to an irritant Source: International Congress 2019 – Indoor and outdoor air quality considerations Year: 2019 Methodological issues of sample collection and analysis of exhaled breath Source: Eur Respir Monogr 2010; 49: 96-114 Year: 2010 Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study Source: ERJ Open Res, 8 (1) 00493-2021; 10.1183/23120541.00493-2021 Year: 2022 Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Differentialion mobility spectrometry (DMS) for discrimination of local gut infection in exhaled breath Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Comparison of a new nitrogen multiple breath washout method to mass spectrometer SF6 washout in cystic fibrosis subjects Source: Annual Congress 2011 - Advances in lung function testing from infancy to adulthood Year: 2011 Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011 Detection of differences in volatile organic compounds (VOCs) by ion mobility spectrometry (IMS) of exhaled breath in patients with interstitial lung diseases (ILDs) compared to healthy controls (HC) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012